The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma.

Volkan Aslan Atiye Cenay Karabörk Kilic Ahmet Özet Aytuğ Üner Nazan Günel Ozan Yazıcı Gözde Savaş Ahmet Bayrak Emrah Eraslan Ömür Berna Çakmak Öksüzoğlu Hüseyin Koray Kılıç Nuriye Ozdemir

Published in: BMC cancer (2023)

Our findings suggest that the change in splenic volume throughout immunotherapy regimens may be utilized to predict PFS and OS in mRCC patients undergoing treatment.

Keyphrases

metastatic renal cell carcinoma
patients undergoing
combination therapy
smoking cessation